ALFA Finder
23:38 IST
NSE
Earnings Call
Amrutanjan Health Care Investor Presentation: Key Takeaways
Q2 FY27 net sales ₹135.2 Cr (+14.9%), PAT ₹17.3 Cr (+23.8%). H1 PAT ₹21.7 Cr, down 2.8% on cost pressure.
Amrutanjan Health Care Ltd
- Share price
- ₹520.15
- Market cap
- ₹1,504 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 26.2×Sector 43.8×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 5Annual General Meeting 5Other Announcement 4Earnings Call 4Board Meeting Date 4Dividend 3Production Started 2Management Change 2Legal & Regulatory 2Employee Stock Options 2Product Launch 1Credit Rating 1Capital Structure Change 1Business Update 1Annual Report 1
Time
4 announcements with these filters
20:35 IST
NSE
Earnings Call
Amrutanjan Health Care Investor Presentation: Key Takeaways
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
- Call
- Guides 10% growth
15:12 IST
BSE
Earnings Call
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported 11.23% revenue growth for FY26 with significant 37.2% jump in Q4 profit before exceptional items. Strategy focuses on power brands, distribution expansion, and digitization.
14:59 IST
NSE
Earnings Call
Amrutanjan Health Care Earnings Call: Key Takeaways
Amrutanjan reported FY26 net sales of ₹502.55 Cr (up 11.23%) and PAT of ₹57.92 Cr (up 13.95%). Strategy focuses on expanding Pain Management, Women's Hygiene, and new Personal Care categories.